全球插管市场：市场规模和占有率分析（依产品、插入途径、应用和最终用户）、工业需求预测（截至 2030 年）

主要亮点

2023年插管市场规模将达27.276亿美元，复合年增长率超过6.5%，并于2030年扩大至42.944亿美元。

道路事故和创伤的增加是该行业的主要驱动力。 交通事故造成的死亡人数每年都在大幅增加。

SARS-CoV-2 的爆发大大增加了行业收入。 冠状病毒的爆发对该行业产生了巨大的积极影响。

关键见解

2023年常规品类占产业占有率40%。 这是由于呼吸系统疾病的发生率急剧上升，导致外科手术量增加。

未来几年，增强型类别将持续维持较高的复合年增长率。 这是由于患有需要手术、脸部手术和交通事故的神经系统疾病的患者数量增加。

气管切开术类别是该行业的最大贡献者，到 2023 年约占 75% 的占有率。 气管插管是这些管子最常见的插入途径，因为它对病人来说更舒适。

2023年，急诊治疗将占最大占有率，约55%。 这是由于心肺骤停、事故、呼吸困难和气道阻塞等紧急情况的发生率不断增加。

北美是该产业的最大贡献者，2023 年约占 60% 的占有率。

北美的成长得益于强大的医疗服务和基础设施、既定的报销政策以及医疗行业对技术改进设备的日益接受。

亚太地区预计在未来 10 年将以最快的复合年增长率成长。 这是因为导致呼吸道疾病的污染程度增加、老年人口迅速增长以及心肺疾病的发病率显着增加，所有这些最终促使手术需求的增加。

本报告分析了全球插管市场，包括市场的基本结构和最新情况、主要促进和抑制因素以及全球、依地区和主要国家的市场规模前景（以货币形式计算） ，（2017-2030） ，依产品、插入路线、应用程式和最终用户划分的详细趋势、市场竞争的现状以及主要公司的概况。

目录

第一章研究范围

第二章研究方法

第 3 章执行摘要

第 4 章市场指标

第五章产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因子影响分析
• 新型冠状病毒感染 (COVID-19) 的影响
• 波特五力分析

第六章世界市场

• 摘要
• 市场收入：依产品分类（2017-2030 年）
• 市场收入：依插入途径划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场收入：以最终用户划分（2017-2030 年）
• 市场收入：依地区划分（2017-2030 年）

第七章北美市场

• 摘要
• 市场收入：依产品分类（2017-2030 年）
• 市场收入：依插入途径划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场收入：以最终用户划分（2017-2030 年）
• 市场收入：依国家/地区划分（2017-2030 年）

第八章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第十一章中东及非洲市场

第12章美国市场

• 摘要
• 市场收入：依产品分类（2017-2030 年）
• 市场收入：依插入途径划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场收入：以最终用户划分（2017-2030 年）

第十三章加拿大市场

第14章德国市场

第十五章法国市场

第十六章英国市场

第十七章义大利市场

第十八章西班牙市场

第十九章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

• 市场参与者及其提供的产品/服务的列表
• 主要公司的竞争基准
• 各大公司的产品基准
• 近期策略发展状况

第30章公司简介

• Teleflex Incorporated
• Medtronic plc
• Medline Industries LP
• Venner Medical International
• Armstrong Medical Inc.
• ICU Medical Inc.
• Convatec Limited

第31章附录

Key Highlights

The intubation tubes market generated a value of USD 2,727.6 million in 2023, and it will increase to USD 4,294.4 million, with more than 6.5% CAGR, by 2030.

The increasing prevalence of road accidents and trauma is a key industry driver. There has been a substantial increase in the count of road accidents resulting in death over the years.

As per the WHO, around 1.5 million people die in road accidents annually.

A substantial emotional trauma to victims' families and economic loss are the extra burdens that come along with such accidents.

Major accidents led to substantial trauma to patients, who then necessitated surgical intervention or immediate treatment, thus boosting the requirement for intubation tubes.

The outbreak of SARS-CoV-2 resulted in exponential growth in industry revenue. The outbreak of coronavirus had a substantial positive impact on this industry.

There was a quick increase in the count of seriously ill patients, for whom intubation was essential in emergencies because one of the main problems that came along with the ailment was difficulty in breathing.

Intubation tubes are an accepted means of delivering breathing support to patients with novel coronavirus.

Key Insights

The regular category accounted for the largest share of the industry in 2023, of 40%. This can be attributed to the increasing volume of surgical measures because of the surging incidence of respiratory diseases.

The reinforced category will propel at a high compound annual growth rate in the years to come. This will be because of the increasing count of patients suffering from neurological conditions needing surgeries and the rising count of facial surgeries and road accidents.

The orotracheal category was the largest contributor to the industry in 2023, with approximately 75% share. Orotracheal is the most common insertion route of these tubes because of its comfort for patients.

Orotracheal is extensively accepted in treating apneic and severely ill patients ailing from multisystem diseases and severe injuries.

Emergency treatment accounted for the largest share in 2023, of approximately 55%. This can be attributed to the increasing incidence of emergencies like cardiopulmonary arrest, accidents, respiratory distress, and obstruction of the airways.

Therapy will propel at a significant CAGR in the years to come. This will be mainly because of the surging count of surgical measures, most of which necessitate intubation tubes for managing the airways.

North America was the largest contributor to the industry in 2023, with a share of approximately 60%.

The growth in North America is due to the robust healthcare services and infrastructure; well-established reimbursement policies, and rising acceptance of technologically improved devices by the medical industry.

APAC is likely to propel at the fastest compound annual growth rate during this decade. This is because of the increasing level of pollution leading to respiratory conditions, surging elderly populace, and substantial incidence of cardiopulmonary illnesses, all of which eventually result in the growing requirement for surgeries.

The intubation tubes industry is very fragmented as well as competitive. Players in this market are continuously involved in strategic initiatives like new product launches, acquisitions, collaborations, and technological improvements, to enhance their presence.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by route
  • 1.4.3. Market size breakdown, by application
  • 1.4.4. Market size breakdown, by end user
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Route (2017-2030)
• 6.4. Market Revenue, by Application (2017-2030)
• 6.5. Market Revenue, by End User (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Route (2017-2030)
• 7.4. Market Revenue, by Application (2017-2030)
• 7.5. Market Revenue, by End User (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Route (2017-2030)
• 8.4. Market Revenue, by Application (2017-2030)
• 8.5. Market Revenue, by End User (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Route (2017-2030)
• 9.4. Market Revenue, by Application (2017-2030)
• 9.5. Market Revenue, by End User (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Route (2017-2030)
• 10.4. Market Revenue, by Application (2017-2030)
• 10.5. Market Revenue, by End User (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Route (2017-2030)
• 11.4. Market Revenue, by Application (2017-2030)
• 11.5. Market Revenue, by End User (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Route (2017-2030)
• 12.4. Market Revenue, by Application (2017-2030)
• 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Route (2017-2030)
• 13.4. Market Revenue, by Application (2017-2030)
• 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Route (2017-2030)
• 14.4. Market Revenue, by Application (2017-2030)
• 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Route (2017-2030)
• 15.4. Market Revenue, by Application (2017-2030)
• 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Route (2017-2030)
• 16.4. Market Revenue, by Application (2017-2030)
• 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Route (2017-2030)
• 17.4. Market Revenue, by Application (2017-2030)
• 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Route (2017-2030)
• 18.4. Market Revenue, by Application (2017-2030)
• 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Route (2017-2030)
• 19.4. Market Revenue, by Application (2017-2030)
• 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Route (2017-2030)
• 20.4. Market Revenue, by Application (2017-2030)
• 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Route (2017-2030)
• 21.4. Market Revenue, by Application (2017-2030)
• 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Route (2017-2030)
• 22.4. Market Revenue, by Application (2017-2030)
• 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Route (2017-2030)
• 23.4. Market Revenue, by Application (2017-2030)
• 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Route (2017-2030)
• 24.4. Market Revenue, by Application (2017-2030)
• 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Route (2017-2030)
• 25.4. Market Revenue, by Application (2017-2030)
• 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Route (2017-2030)
• 26.4. Market Revenue, by Application (2017-2030)
• 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Route (2017-2030)
• 27.4. Market Revenue, by Application (2017-2030)
• 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Route (2017-2030)
• 28.4. Market Revenue, by Application (2017-2030)
• 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Teleflex Incorporated
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Medtronic plc
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Medline Industries LP
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Venner Medical International
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Armstrong Medical Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. ICU Medical Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Convatec Limited
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports